Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;633(8030):634-645.
doi: 10.1038/s41586-024-07871-6. Epub 2024 Aug 28.

Cellular communities reveal trajectories of brain ageing and Alzheimer's disease

Gilad Sahar Green  1 , Masashi Fujita #  2 , Hyun-Sik Yang #  3   4   5 , Mariko Taga  2 , Anael Cain  1 , Cristin McCabe  6 , Natacha Comandante-Lou  2 , Charles C White  4 , Anna K Schmidtner  1 , Lu Zeng  2 , Alina Sigalov  2 , Yangling Wang  7 , Aviv Regev  6   8   9 , Hans-Ulrich Klein  2 , Vilas Menon  10 , David A Bennett  7 , Naomi Habib  11   12 , Philip L De Jager  13   14
Affiliations

Cellular communities reveal trajectories of brain ageing and Alzheimer's disease

Gilad Sahar Green et al. Nature. 2024 Sep.

Abstract

Alzheimer's disease (AD) has recently been associated with diverse cell states1-11, yet when and how these states affect the onset of AD remains unclear. Here we used a data-driven approach to reconstruct the dynamics of the brain's cellular environment and identified a trajectory leading to AD that is distinct from other ageing-related effects. First, we built a comprehensive cell atlas of the aged prefrontal cortex from 1.65 million single-nucleus RNA-sequencing profiles sampled from 437 older individuals, and identified specific glial and neuronal subpopulations associated with AD-related traits. Causal modelling then prioritized two distinct lipid-associated microglial subpopulations-one drives amyloid-β proteinopathy while the other mediates the effect of amyloid-β on tau proteinopathy-as well as an astrocyte subpopulation that mediates the effect of tau on cognitive decline. To model the dynamics of cellular environments, we devised the BEYOND methodology, which identified two distinct trajectories of brain ageing, each defined by coordinated progressive changes in certain cellular communities that lead to (1) AD dementia or (2) alternative brain ageing. Thus, we provide a cellular foundation for a new perspective on AD pathophysiology that informs personalized therapeutic development, targeting different cellular communities for individuals on the path to AD or to alternative brain ageing.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • A cross-disease resource of living human microglia identifies disease-enriched subsets and tool compounds recapitulating microglial states.
    Tuddenham JF, Taga M, Haage V, Marshe VS, Roostaei T, White C, Lee AJ, Fujita M, Khairallah A, Zhang Y, Green G, Hyman B, Frosch M, Hopp S, Beach TG, Serrano GE, Corboy J, Habib N, Klein HU, Soni RK, Teich AF, Hickman RA, Alcalay RN, Shneider N, Schneider J, Sims PA, Bennett DA, Olah M, Menon V, De Jager PL. Tuddenham JF, et al. Nat Neurosci. 2024 Oct 15. doi: 10.1038/s41593-024-01764-7. Online ahead of print. Nat Neurosci. 2024. PMID: 39406950
  • Integrated multimodal cell atlas of Alzheimer's disease.
    Gabitto MI, Travaglini KJ, Rachleff VM, Kaplan ES, Long B, Ariza J, Ding Y, Mahoney JT, Dee N, Goldy J, Melief EJ, Agrawal A, Kana O, Zhen X, Barlow ST, Brouner K, Campos J, Campos J, Carr AJ, Casper T, Chakrabarty R, Clark M, Cool J, Dalley R, Darvas M, Ding SL, Dolbeare T, Egdorf T, Esposito L, Ferrer R, Fleckenstein LE, Gala R, Gary A, Gelfand E, Gloe J, Guilford N, Guzman J, Hirschstein D, Ho W, Hupp M, Jarsky T, Johansen N, Kalmbach BE, Keene LM, Khawand S, Kilgore MD, Kirkland A, Kunst M, Lee BR, Leytze M, Mac Donald CL, Malone J, Maltzer Z, Martin N, McCue R, McMillen D, Mena G, Meyerdierks E, Meyers KP, Mollenkopf T, Montine M, Nolan AL, Nyhus JK, Olsen PA, Pacleb M, Pagan CM, Peña N, Pham T, Pom CA, Postupna N, Rimorin C, Ruiz A, Saldi GA, Schantz AM, Shapovalova NV, Sorensen SA, Staats B, Sullivan M, Sunkin SM, Thompson C, Tieu M, Ting JT, Torkelson A, Tran T, Valera Cuevas NJ, Walling-Bell S, Wang MQ, Waters J, Wilson AM, Xiao M, Haynor D, Gatto NM, Jayadev S, Mufti S, Ng L, Mukherjee S, Crane PK, Latimer CS, Levi BP, Smith KA, Close JL, Miller JA, Hodge RD, Larson EB, Grabowski TJ, Hawrylycz M, Keene CD, Lein ES. Gabitto MI, et al. Nat Neurosci. 2024 Oct 14. doi: 10.1038/s41593-024-01774-5. Online ahead of print. Nat Neurosci. 2024. PMID: 39402379

References

    1. Cain, A. et al. Multicellular communities are perturbed in the aging human brain and Alzheimer’s disease. Nat. Neurosci. 26, 1267–1280 (2023). - PubMed - PMC - DOI
    1. Mathys, H. et al. Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer’s disease pathology. Cell 186, 4365–4385 (2023). - PubMed - DOI
    1. Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk. Nature 603, 885–892 (2022). - PubMed - PMC - DOI
    1. Pandey, S. et al. Disease-associated oligodendrocyte responses across neurodegenerative diseases. Cell Rep. 40, 111189 (2022). - PubMed - DOI
    1. Luquez, T. et al. Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease. Genome Med. 14, 136 (2022). - PubMed - PMC - DOI

MeSH terms

LinkOut - more resources